◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...

Appili Therapeutics Inc.

Financial Statements (IFRS) · Amounts in CAD
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line Item Q3 2025Sep 30, 2025 Q2 2025Jun 30, 2025 Q1 2025Mar 31, 2025 Q4 2024Dec 31, 2024 Q3 2024Sep 30, 2024
Total Revenue 103,935 0.00 -12,606 108,359 4,690
Operating Revenue 103,935 0.00 -12,606 108,359 4,690
Selling General And Administration 564,228 642,469 991,764 443,261 653,638
General And Administrative Expense 564,228 642,469 991,764 443,261 653,638
Research And Development 838,352 960,973 1.5M 1.7M 2.1M
Other Operating Expenses -223,069 -550,886 -2.5M -2.6M -2.4M
Operating Expense 1.2M 1.1M 49,197 -388,713 333,703
Operating Income -1.1M -1.1M -61,803 497,072 -329,013
EBIT -1.1M -732,656 925,237 -12,280 -212,045
Interest Expense -- 486,066 669,552 522,022 530,289
Interest Expense Non Operating -- 486,066 669,552 522,022 530,289
Interest Income 218,439 -- 0.00 36.00 0.00
Interest Income Non Operating 218,439 -- 0.00 36.00 0.00
Net Interest Income 218,439 -486,066 -1.2M -521,986 -530,289
Other Income Expense -96,962 319,900 1.5M -509,388 116,968
Gain On Sale Of Security -96,962 319,900 119,977 -509,388 116,968
Pretax Income -954,099 -1.2M 255,685 -534,302 -742,334
Tax Provision 34,966 30,859 27,635 -9,965 1,160
Tax Effect Of Unusual Items -14,544 47,985 12,967 -9,500 17,545
Net Income From Continuing And Discontinued Operation -989,065 -1.2M 228,050 -524,337 -743,494
Net Income From Continuing Operation Net Minority Interest -989,065 -1.2M 228,050 -524,337 -743,494
Net Income Including Noncontrolling Interests -989,065 -1.2M 228,050 -524,337 -743,494
Net Income Common Stockholders -989,065 -1.2M 228,050 -524,337 -743,494
Net Income -989,065 -1.2M 228,050 -524,337 -743,494
EBITDA -1.1M -729,040 928,445 -8,205 -209,233
Normalized EBITDA -975,369 -1.0M 808,468 501,183 -326,201
Reconciled Depreciation 3,245 3,616 3,208 4,075 2,812
Basic EPS -0.01 -0.01 -- 0.00 -0.01
Diluted EPS -0.01 -0.01 -- 0.00 -0.01
Basic Average Shares 121.3M 121.3M -- 121.3M 121.3M
Diluted Average Shares 121.3M 121.3M -- 121.3M 121.3M
Total Unusual Items -96,962 319,900 119,977 -509,388 116,968
Total Unusual Items Excluding Goodwill -96,962 319,900 119,977 -509,388 116,968
Tax Rate For Calcs 0.15 0.15 0.11 0.02 0.15
Normalized Income -906,647 -1.5M 121,040 -24,449 -842,917
Diluted NI Availto Com Stockholders -989,065 -1.2M 228,050 -524,337 -743,494
Net Income Continuous Operations -989,065 -1.2M 228,050 -524,337 -743,494
Net Non Operating Interest Income Expense 218,439 -486,066 -1.2M -521,986 -530,289
Other Gand A 564,228 642,469 991,764 443,261 653,638
Total Expenses 1.2M 1.1M 49,197 -388,713 333,703
Line Item Q3 2025Sep 30, 2025 Q2 2025Jun 30, 2025 Q1 2025Mar 31, 2025 Q4 2024Dec 31, 2024 Q3 2024Sep 30, 2024
Cash And Cash Equivalents 348,679 1.1M 1.2M 186,166 665,219
Cash Cash Equivalents And Short Term Investments 348,679 1.1M 1.2M 186,166 665,219
Cash Financial 348,679 1.1M 1.2M 186,166 665,219
Receivables 201,593 515,288 1.7M 1.8M 750,675
Prepaid Assets 192,004 244,378 114,514 125,772 112,690
Current Assets 742,276 1.9M 3.0M 2.1M 1.5M
Net PPE 12,182 15,427 19,043 22,250 25,623
Total Non Current Assets 12,182 15,427 19,043 22,250 25,623
Total Assets 754,458 1.9M 3.0M 2.1M 1.6M
Current Debt 11.6M 11.6M 11.6M 10.5M 9.6M
Current Debt And Capital Lease Obligation 11.6M 11.6M 11.6M 10.5M 9.6M
Accounts Payable 4.1M 4.2M 4.1M 4.4M 4.2M
Payables 4.1M 4.2M 4.1M 4.4M 4.2M
Payables And Accrued Expenses 4.1M 4.2M 4.1M 4.4M 4.2M
Current Liabilities 15.8M 15.8M 15.7M 14.9M 13.9M
Long Term Debt 609,000 703,200 736,100 811,400 814,100
Long Term Debt And Capital Lease Obligation 609,000 703,200 736,100 811,400 814,100
Total Non Current Liabilities Net Minority Interest 609,000 703,200 736,100 811,400 814,100
Total Liabilities Net Minority Interest 16.4M 16.5M 16.4M 15.7M 14.7M
Common Stock 42.3M 42.3M 42.3M 42.3M 42.3M
Capital Stock 42.3M 42.3M 42.3M 42.3M 42.3M
Additional Paid In Capital 15.5M 14.8M 14.8M 14.8M 13.1M
Retained Earnings -74.0M -73.0M -71.7M -71.9M -71.4M
Common Stock Equity -15.6M -14.6M -13.4M -13.6M -13.1M
Stockholders Equity -15.6M -14.6M -13.4M -13.6M -13.1M
Total Equity Gross Minority Interest -15.6M -14.6M -13.4M -13.6M -13.1M
Total Capitalization -15.0M -13.9M -12.7M -12.8M -12.3M
Net Tangible Assets -15.6M -14.6M -13.4M -13.6M -13.1M
Tangible Book Value -15.6M -14.6M -13.4M -13.6M -13.1M
Working Capital -15.0M -13.9M -12.7M -12.8M -12.3M
Invested Capital -3.4M -2.3M -1.1M -2.3M -2.7M
Total Debt 12.2M 12.4M 12.3M 11.3M 10.4M
Net Debt 11.9M 11.2M 11.1M 11.1M 9.8M
Share Issued 121.3M 121.3M 121.3M 121.3M 121.3M
Ordinary Shares Number 121.3M 121.3M 121.3M 121.3M 121.3M
Other Equity Interest 564,434 1.2M 1.2M 1.2M 2.8M
Other Receivables 149,706 425,314 1.6M 1.7M 664,169
Taxes Receivable 51,887 89,974 71,540 90,772 86,506
Total Tax Payable 15,198 15,602 29,471 1,846 42,496
Line Item Q3 2025Sep 30, 2025 Q2 2025Jun 30, 2025 Q1 2025Mar 31, 2025 Q4 2024Dec 31, 2024 Q3 2024Sep 30, 2024
Operating Cash Flow -759,376 -6,356 1.0M -442,371 409,027
Cash Flow From Continuing Operating Activities -759,376 -6,356 1.0M -442,371 409,027
Depreciation And Amortization 3,245 3,616 3,208 4,075 2,812
Depreciation Amortization Depletion 3,245 3,616 3,208 4,075 2,812
Stock Based Compensation 11,576 18,096 10,688 12,834 14,266
Change In Working Capital 326,986 1.1M -200,831 -833,191 722,091
Changes In Account Receivables 303,695 1.2M 91,903 -1.0M 1.0M
Change In Receivables 313,695 1.2M 88,603 -1.0M 1.0M
Change In Payables And Accrued Expense -39,083 41,612 -300,692 188,692 -319,581
Change In Payable -- -- -- -- --
Other Non Cash Items 92,806 473,570 1.2M 507,842 509,249
Capital Expenditure -- -- -- -702.00 --
Purchase Of PPE 0.00 0.00 0.00 -702.00 -1,658
Net PPE Purchase And Sale 0.00 0.00 0.00 -702.00 -1,658
Investing Cash Flow 0.00 0.00 0.00 -702.00 -1,658
Cash Flow From Continuing Investing Activities 0.00 0.00 0.00 -702.00 -1,658
Issuance Of Debt 0.00 0.00 0.00 0.00 0.00
Repayment Of Debt -30,091 -29,298 -44,856 -27,556 -26,645
Net Issuance Payments Of Debt -30,091 -29,298 -44,856 -27,556 -26,645
Financing Cash Flow -77,415 -42,283 -61,209 -40,562 -42,973
Cash Flow From Continuing Financing Activities -77,415 -42,283 -61,209 -40,562 -42,973
Effect Of Exchange Rate Changes 60,421 -54,556 69,052 4,582 -442.00
Changes In Cash -836,791 -48,639 973,026 -483,635 364,396
Beginning Cash Position 1.1M 1.2M 186,166 665,219 301,265
End Cash Position 348,679 1.1M 1.2M 186,166 665,219
Free Cash Flow -759,376 -6,356 1.0M -443,073 407,369
Interest Paid Supplemental Data -- -- -- -1.0M 1.0M
Cash Dividends Paid 0.00 0.00 0.00 0.00 0.00
Change In Account Payable -- -- -- -- --
Change In Prepaid Assets 52,374 -129,864 11,258 -13,082 4,010
Depreciation 3,245 3,616 3,208 4,075 2,812
Interest Paid Cff -47,324 -12,985 -16,353 -13,006 -16,328
Long Term Debt Issuance 0.00 0.00 0.00 0.00 0.00
Long Term Debt Payments -30,091 -29,298 -44,856 -27,556 -26,645
Net Foreign Currency Exchange Gain Loss -204,923 -319,390 -177,013 390,406 -95,897
Net Income From Continuing Operations -989,066 -1.2M 228,050 -524,337 -743,494
Net Long Term Debt Issuance -30,091 -29,298 -44,856 -27,556 -26,645
Operating Gains Losses -204,923 -319,390 -177,013 390,406 -95,897
NEWS
Loading news...
TRENDING
Loading...